Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2010
12/15/2010CN101918386A 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2-phenylcyclohexane-1,3,5-triones as herbicides
12/15/2010CN101918384A Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
12/15/2010CN101918369A N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (HCV) inhibitors
12/15/2010CN101918365A Inhibitors of human immunodeficiency virus replication
12/15/2010CN101918363A Phenyl acetamide derivative
12/15/2010CN101918362A Pyridine derivatives
12/15/2010CN101915946A Ophthalmic devices comprising photochromic materials with reactive substituents
12/15/2010CN101914093A Reactive heterocycle-substituted 7-hydroxycoumarins and their conjugates
12/15/2010CN101914084A Derivative of diphenylpyrone nitrogen heterocyclic ring as well as preparation method and application thereof
12/15/2010CN101914081A Aurone compound, synthesis method and application thereof in weeding
12/15/2010CN101914065A Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by crth2
12/15/2010CN101429195B Process for producing important synthesis midbody of high purity atorvastatin
12/15/2010CN101255132B 6-aryl-3-substituted methylene-pyridinone derivatives and uses thereof
12/14/2010US7853026 Digital sound processing system for a vehicle
12/14/2010US7851634 enzyme inhibitors such as N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2-isopropyl-7-[3-(3-methoxypropyl)-1H-indol-5-ylmethyl]-8-methylnonanamide, used as hypotensive agents
12/14/2010US7851632 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation
12/14/2010US7851471 Compounds I
12/14/2010CA2430909C Inhibitors of papilloma virus
12/14/2010CA2414787C Coumarin derivatives with comt inhibiting activity
12/14/2010CA2373433C Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
12/14/2010CA2159546C Cycloalkano-indole and -azaindole derivatives
12/09/2010WO2010141932A1 Aminopyrrolidinone derivatives and uses thereof
12/09/2010WO2010141805A1 Heterocyclic amides as modulators of trpa1
12/09/2010WO2010141584A2 Antagonism of human formyl peptide receptor for treatment of disease
12/09/2010WO2010141525A1 Active metabolite of a thrombin receptor antagonist
12/09/2010WO2010140802A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/09/2010WO2010140636A1 Asymmetric hydrogenation catalyst
12/09/2010WO2010139266A1 Methods for synthesizing 3-(substituted dihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and intermediates thereof
12/09/2010WO2010091386A3 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
12/09/2010US20100311965 2-aminoquinazoline derivative
12/09/2010US20100311795 1,3-dioxane carboxylic acids
12/09/2010US20100311792 Benzenesulfonamide Compounds and the Use Thereof
12/09/2010US20100311789 3-Substituted Propanamine Compounds
12/09/2010US20100311778 Chromane derivatives as trpv3 modulators
12/09/2010US20100311773 Novel anabaseine derivatives, pharmaceutical compositions and methods of use thereof
12/09/2010US20100311749 4-benzoyl-1-substituted-piperazin-2-one derivatives as p2x7 modulators
12/09/2010US20100311735 Inhibitors of human immunodeficiency virus replication
12/09/2010US20100311728 Manipulation of brain CDP-diacylglycerol and uses thereof
12/09/2010US20100311713 Novel Azetidine Compounds Useful in the Treatment of Functional Gastrointestinal Disorders, Ibs and Functional Dyspepsia
12/09/2010US20100311709 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA [f]INDAZOLE-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
12/09/2010US20100311582 Chemical compounds
12/09/2010US20100311581 Azolylmethyloxiranes, use Thereof and Agents Containing the Same
12/09/2010US20100310722 Beverage Preservative System Containing Pimaricin-Povidone Complex
12/09/2010US20100310657 Pharmaceutical composition for treatment and prevention of kidney diseases
12/09/2010CA2764387A1 Aminopyrrolidinone derivatives and uses thereof
12/09/2010CA2764159A1 Active metabolite of a thrombin receptor antagonist
12/09/2010CA2763893A1 Antagonism of human formyl peptide receptor for treatment of disease
12/08/2010EP2259068A2 Capture compounds and methods for analyzing the proteome
12/08/2010EP2258706A2 Functionalized ionic liquids, and methods of use thereof
12/08/2010EP2258703A1 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2258690A1 Tricyclic amines as intermediates in the synthesis of fungicidal carboxamide derivatives
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258366A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
12/08/2010EP2257548A1 Therapeutic compounds
12/08/2010EP2257539A1 Substituted 4-hydroxypyrimidine-5-carboxamides
12/08/2010EP2257535A1 Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators
12/08/2010EP2257534A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
12/08/2010EP2257528A2 1 ibeta-hydroxysteroid dehydrogenase inhibitors
12/08/2010EP2257297A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
12/08/2010EP2257167A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
12/08/2010EP2257160A1 Diamide inhibitors of cytochrome p450
12/08/2010EP2139885B1 Co-crystals of propiconazole
12/08/2010EP1891011B1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5
12/08/2010EP1858857B1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
12/08/2010CN101910156A Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
12/08/2010CN101910155A Biphenyl derivatives as modulators of the histamine-H3 receptor useful for the treatment of disorders related thereto
12/08/2010CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/08/2010CN101910136A Fluorescent agent having ethynyl group
12/08/2010CN101910134A Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids
12/08/2010CN101910133A Heterocycle phenyl amide T-type calcium channel antagonists
12/08/2010CN101910131A Carboxamide, sulfonamide and amine compounds for metabolic disorders
12/08/2010CN101910129A Synthesis of quaternary salt compounds
12/08/2010CN101910121A Bis-(sulfonylamino) derivatives in therapy 066
12/08/2010CN101909629A Crystalline (R)-2-(4-cyclopropanesulphonyl-phenyl)-N-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide
12/08/2010CN101906097A 1,3-dioxane compounds as well as synthesizing method and medical application thereof
12/08/2010CN101906096A 3,4-dihydropyridine-2-ketone heterocyclic compound and application thereof
12/08/2010CN101906071A Dioxane-2-alkyl carbamates derivatives
12/08/2010CN101906029A Flavonoid derivative , preparation method thereof and use thereof
12/08/2010CN101220022B 2-(5-chlorophenyl-2-tetrol formamido)ethanamide pyrimidine derivant, preparation and application thereof
12/08/2010CN101220021B 4-substituted phenoxyl quinoline compounds and midbody, production method, application thereof
12/07/2010US7846959 Raf modulators and methods of use
12/07/2010US7846950 Histamine H3 receptor inhibitors, preparation and therapeutic uses
12/07/2010US7846945 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents
12/07/2010US7846933 such as 1-(4-Fluorophenyl)-5-(pyridin-4-yl)-4-imidazolin-2-one, having excellent p38 MAP kinase inhibitory action, useful for the treatment of osteoarthritis, arthritis, ulcerative colitis, Crohn's disease, psoriasis, dermatitis, asthma, bronchitis, pneumonia, rhinitis, conjunctivitis or keratitis
12/07/2010US7846926 podophyllotoxin derivatives such as (2-{3-[4-(3-aminopropylamino)-butylamino]-propylamino}-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5,6,8,8a,9-hexahydrofuro[3',4':6,7]naptho[2,3-d][1,3]dioxol-5-yl]-acetamide, used as anticarcinogenic agents
12/07/2010US7846922 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators
12/07/2010CA2583084C 7,8-bicycloalkyl-chroman derivatives
12/07/2010CA2577430C 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione and analogues as inhibitors of macrophage elastase
12/07/2010CA2471883C Phenylpyrimidine amines as ige inhibitors
12/07/2010CA2374995C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/07/2010CA2299632C Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
12/02/2010WO2010138484A2 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010136559A1 2, 4 -diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
12/02/2010WO2010136145A1 Pyrazinylpyrazoles
12/02/2010WO2010136037A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010WO2010083384A3 Non-peptidyl, potent, and selective mu opioid receptor antagonists
12/02/2010WO2010069502A3 Tetrazole substituted anthranilic acid amides as pesticides
1 ... 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 ... 694